Reviews - 1if9 mentioned but not cited (1)
- Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. Krishnamurthy VM, Kaufman GK, Urbach AR, Gitlin I, Gudiksen KL, Weibel DB, Whitesides GM. Chem Rev 108 946-1051 (2008)
Articles - 1if9 mentioned but not cited (1)
- Insights towards sulfonamide drug specificity in α-carbonic anhydrases. Aggarwal M, Kondeti B, McKenna R. Bioorg Med Chem 21 1526-1533 (2013)
Reviews citing this publication (10)
- Carbonic anhydrase inhibitors. Supuran CT, Scozzafava A, Casini A. Med Res Rev 23 146-189 (2003)
- Computer-based de novo design of drug-like molecules. Schneider G, Fechner U. Nat Rev Drug Discov 4 649-663 (2005)
- Lead discovery using molecular docking. Shoichet BK, McGovern SL, Wei B, Irwin JJ. Curr Opin Chem Biol 6 439-446 (2002)
- The genesis of high-throughput structure-based drug discovery using protein crystallography. Kuhn P, Wilson K, Patch MG, Stevens RC. Curr Opin Chem Biol 6 704-710 (2002)
- From laptop to benchtop to bedside: structure-based drug design on protein targets. Chen L, Morrow JK, Tran HT, Phatak SS, Du-Cuny L, Zhang S. Curr Pharm Des 18 1217-1239 (2012)
- Shape Signatures: speeding up computer aided drug discovery. Meek PJ, Liu Z, Tian L, Wang CY, Welsh WJ, Zauhar RJ. Drug Discov Today 11 895-904 (2006)
- De novo design: balancing novelty and confined chemical space. Kutchukian PS, Shakhnovich EI. Expert Opin Drug Discov 5 789-812 (2010)
- Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design. Linkuvienė V, Zubrienė A, Manakova E, Petrauskas V, Baranauskienė L, Zakšauskas A, Smirnov A, Gražulis S, Ladbury JE, Matulis D. Q Rev Biophys 51 e10 (2018)
- Rare Diseases: Drug Discovery and Informatics Resource. Zhao M, Wei DQ. Interdiscip Sci 10 195-204 (2018)
- Structure-directed combinatorial library design. Zhou JZ. Curr Opin Chem Biol 12 379-385 (2008)
Articles citing this publication (18)
- Rescoring docking hit lists for model cavity sites: predictions and experimental testing. Graves AP, Shivakumar DM, Boyce SE, Jacobson MP, Case DA, Shoichet BK. J Mol Biol 377 914-934 (2008)
- In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II. Mocharla VP, Colasson B, Lee LV, Röper S, Sharpless KB, Wong CH, Kolb HC. Angew Chem Int Ed Engl 44 116-120 (2004)
- Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. Avvaru BS, Wagner JM, Maresca A, Scozzafava A, Robbins AH, Supuran CT, McKenna R. Bioorg Med Chem Lett 20 4376-4381 (2010)
- Decoys for docking. Graves AP, Brenk R, Shoichet BK. J Med Chem 48 3714-3728 (2005)
- In situ click chemistry: a powerful means for lead discovery. Sharpless KB, Manetsch R. Expert Opin Drug Discov 1 525-538 (2006)
- A validation study on the practical use of automated de novo design. Stahl M, Todorov NP, James T, Mauser H, Boehm HJ, Dean PM. J Comput Aided Mol Des 16 459-478 (2002)
- Scoring functions for protein-ligand interactions: a critical perspective. Schulz-Gasch T, Stahl M. Drug Discov Today Technol 1 231-239 (2004)
- Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides. Remko M, von der Lieth CW. Bioorg Med Chem 12 5395-5403 (2004)
- Human carbonic anhydrase II as a host for piano-stool complexes bearing a sulfonamide anchor. Monnard FW, Heinisch T, Nogueira ES, Schirmer T, Ward TR. Chem Commun (Camb) 47 8238-8240 (2011)
- A general approach for developing system-specific functions to score protein-ligand docked complexes using support vector inductive logic programming. Amini A, Shrimpton PJ, Muggleton SH, Sternberg MJ. Proteins 69 823-831 (2007)
- Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications. Zhao M, Zhou Q, Ma W, Wei DQ. Evid Based Complement Alternat Med 2013 806072 (2013)
- SkelGen: a general tool for structure-based de novo ligand design. Dean PM, Firth-Clark S, Harris W, Kirton SB, Todorov NP. Expert Opin Drug Discov 1 179-189 (2006)
- Inter-residue distances derived from fold contact propensities correlate with evolutionary substitution costs. Williams G, Doherty P. BMC Bioinformatics 5 153 (2004)
- Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILD. Bhurruth-Alcor Y, Røst T, Jorgensen MR, Kontogiorgis C, Skorve J, Cooper RG, Sheridan JM, Hamilton WD, Heal JR, Berge RK, Miller AD. Org Biomol Chem 9 1169-1188 (2011)
- Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods and applications. Zhao M, Wei D. Adv Exp Med Biol 827 227-257 (2015)
- Computational redesign of bacterial biotin carboxylase inhibitors using structure-based virtual screening of combinatorial libraries. Brylinski M, Waldrop GL. Molecules 19 4021-4045 (2014)
- Module assembly for protein-surface recognition: geranylgeranyltransferase I bivalent inhibitors for simultaneous targeting of interior and exterior protein surfaces. Machida S, Usuba K, Blaskovich MA, Yano A, Harada K, Sebti SM, Kato N, Ohkanda J. Chemistry 14 1392-1401 (2008)
- Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores. Karges J, Stokes RW, Cohen SM. ACS Med Chem Lett 13 428-435 (2022)